Skip to content

If you've been putting off filling a prescription because of cost, there's some good news on the horizon—but also some important changes you need to know about. Canada's national pharmacare program is rolling out across the country in 2026, and it's already making a real difference for people managing diabetes and contraception costs. At the same time, new drug pricing rules are coming into effect that could push prescription costs higher for other medications. Here's what you need to know about drug costs in Canada right now, what's covered, and how to navigate the system.

What's Happening with Drug Prices in Canada in 2026

Canada has a significant drug pricing problem. We already pay the 4th highest prices for patented drugs among 31 OECD countries, with per capita spending at US $990 per year. But things are about to get more expensive.

Starting January 1, 2026, new guidelines from the Patented Medicine Prices Review Board (PMPRB) are changing how drug prices are set in Canada. Instead of using the median price from 11 peer countries as the benchmark, Canada will now allow prices to go up to the highest price in that basket of countries. This shift alone could increase drug costs by 21 per cent for new patented medicines.

Making matters worse, the PMPRB has also removed therapeutic value as a pricing factor. In the past, if a new drug offered only modest improvements over existing treatments, it would be priced lower. That's no longer the case. These changes mean you'll likely see steeper prices for newly approved medications.

The impact on Canadians is real. Statistics Canada reports that 11 per cent of men and over 15 per cent of women have skipped or delayed taking prescribed medications because they couldn't afford them.

National Pharmacare: What's Being Covered Right Now

The good news is that the federal government's national pharmacare program is expanding access to free medications. The Pharmacare Act, which came into force in October 2024, is creating universal, single-payer, first-dollar coverage for specific drugs.

Diabetes Medications and Supplies

If you manage diabetes, national pharmacare is a game-changer. The program covers a range of medications at no cost, including:

  • Metformin (typically costs about $100 per year without coverage)
  • Insulin (can range from $900 to $1,700 per year)
  • Sulfonylureas and SGLT-2 inhibitors (can cost $100 to over $1,000 per year)

Beyond medications, the program also covers supplies you need to manage your condition, such as insulin pumps, syringes, glucose monitors, and test strips.

Contraception and Menopausal Hormone Therapy

National pharmacare covers a range of birth control options and contraceptive medications at no cost. In British Columbia, for example, the program—which launches March 1, 2026—also includes menopausal hormone therapy (MHT).

Which Provinces and Territories Are Participating?

As of early 2026, the federal government has reached bilateral agreements with four provinces and territories to fund pharmacare. These include:

  • British Columbia (Plan NP launches March 1, 2026)
  • Manitoba
  • Prince Edward Island
  • Yukon

Negotiations with the remaining nine provinces and territories are ongoing. If your province or territory isn't listed, contact your provincial or territorial health ministry to find out what prescription drug coverage is available to you.

What Exactly Is Covered?

National pharmacare covers the cost of listed medications and products, including the dispensing fee. However, it does not cover delivery fees or pharmacist prescribing fees.

If you're prescribed a more expensive version of a covered drug, you'll need to pay the difference yourself. For example, in British Columbia, some diabetes benefits are subject to Low Cost Alternative (LCA) pricing, meaning you can access 100 per cent coverage if you use the listed medication, but you'll pay out-of-pocket if you choose a pricier alternative.

If you already have private drug insurance, here's what you should know: the public pharmacare plan will supersede your private coverage with no coordination of benefits. This means you'll receive coverage through the national program instead of your private plan.

The Cost of National Pharmacare

The federal government initially allocated $1.5 billion over five years beginning in 2024-25 for the first phase of pharmacare. However, costs are already climbing. The Parliamentary Budget Officer (PBO) estimated that just the first phase will cost $1.9 billion over five years—an increase of $400 million from the original estimate.

If the program expands to cover a broader list of "essential prescription drugs," the full implementation could reach $13.4 billion in annual federal and provincial spending by 2027-28.

This raises important questions about funding. The four bilateral agreements already announced have committed $928.5 million—or 62 per cent of the total funding envelope—while only representing 18 per cent of Canada's population. The government may need to return to Parliament to seek additional funding as more provinces and territories join the program.

What's Not Covered by National Pharmacare

It's crucial to understand that national pharmacare is not a comprehensive drug coverage program—at least not yet. The current rollout focuses exclusively on contraception and diabetes medications. Other prescription drugs, including medications for heart disease, high blood pressure, mental health conditions, and countless other health issues, are not covered under this program.

If you take medications outside these categories, you'll still rely on:

  • Private insurance through your employer
  • Provincial or territorial coverage (which varies by jurisdiction)
  • Paying out-of-pocket
  • Generic drug discounts (generic medications are at least 45 per cent less expensive than brand-name equivalents)

The Bigger Picture: Generic Drugs and Future Costs

One factor that could significantly impact your prescription costs in the coming years is the availability of generic drugs. Generic medications are at least 45 per cent less expensive than brand-name drugs and make up over 75 per cent of all prescriptions in Canada.

However, the renegotiation of CUSMA (Canada-United States-Mexico Agreement) beginning in 2026 could change this. Stronger intellectual property protections could delay the introduction of generic drugs to the Canadian market, which would increase overall drug spending.

Practical Tips for Managing Drug Costs in 2026

While you wait for more provinces to join pharmacare and navigate the current system, here are actionable steps you can take:

  • Check if you're eligible for pharmacare. If you have diabetes or need contraception and live in BC, Manitoba, PEI, or Yukon, visit your provincial health ministry's website to confirm your coverage and find the full list of covered medications.
  • Ask about generic alternatives. When your doctor prescribes a medication, ask if a generic version is available. You'll save significantly, and your doctor can usually switch your prescription without any health impact.
  • Review your private insurance. If you have employer-sponsored drug coverage, understand what's covered and what your out-of-pocket costs are. Some plans cover a percentage of costs rather than the full amount.
  • Use pharmacy discount programs. Many pharmacies offer loyalty programs or discounts on medications not covered by insurance. Ask your pharmacist what's available.
  • Talk to your healthcare provider. If cost is preventing you from taking prescribed medications, tell your doctor. They may be able to suggest more affordable alternatives or help you access patient assistance programs.

What You Should Do Next

Start by determining whether you're eligible for national pharmacare. If you live in British Columbia, Manitoba, Prince Edward Island, or Yukon and take diabetes medications or contraceptives, visit your provincial health ministry's website to understand your coverage and find the complete list of covered medications. If your province hasn't joined yet, stay informed about negotiations and reach out to your provincial health ministry to ask when an agreement might be finalized.

For medications not covered by pharmacare, have a conversation with your doctor or pharmacist about generic alternatives and cost-saving strategies. Don't skip medications because of cost—there are often solutions available, from patient assistance programs to pharmacy discounts to alternative treatments.

Finally, keep an eye on national pharmacare's expansion. The program is evolving, and additional medications and provinces may be added in the coming months and years. The more you understand the current system, the better equipped you'll be to access affordable medications and manage your health costs effectively.

Frequently Asked Questions

A: The rollout varies by province. British Columbia's National Pharmacare Plan launches March 1, 2026[6]. Other provinces that have signed agreements (Manitoba, PEI, and Yukon) are implementing their own timelines. If your province hasn't signed an agreement yet, contact your provincial health ministry for updates.
A: Yes. If you have private coverage, the national pharmacare plan will supersede it for covered medications, with no coordination of benefits[5]. This means you'll receive coverage through the public plan instead of submitting claims to your private insurer.
A: Yes, national pharmacare covers the full cost of listed diabetes medications and related supplies, including insulin, glucose monitors, test strips, insulin pumps, and syringes[4][6]. However, some medications may be subject to Low Cost Alternative pricing, meaning you'll have 100 per cent coverage for the listed version but will pay the difference if you choose a more expensive alternative.
A: The federal government is still negotiating with nine remaining provinces and territories[3]. In the meantime, check your provincial or territorial health ministry's website for information about prescription drug coverage available to you. You may also qualify for patient assistance programs offered by pharmaceutical manufacturers.
A: Yes. New PMPRB guidelines effective January 1, 2026, allow launch prices for new patented medicines to reach the highest price in a basket of peer countries, rather than the median[1]. This could increase prices by up to 21 per cent for newly approved drugs[1].
A: Ask your doctor or pharmacist about generic alternatives (which cost at least 45 per cent less)[1], use pharmacy discount programs, review your private insurance coverage, and speak with your healthcare provider if cost is a barrier to taking your medications.
Share:

Comments (0)

Log in or sign up to leave a comment.

No comments yet. Be the first to share your thoughts!